What is Founders Science Group?
Established in 2014, Founders Science Group operates as an FDA-registered, GMP-compliant testing facility that serves as a critical node in the product development lifecycle. The company specializes in a comprehensive suite of analytical services, including rigorous stability testing, method development, and formulation optimization. By bridging the gap between laboratory research and commercial viability, the firm enables clients in the pharmaceutical, cosmetic, and personal care industries to navigate complex regulatory landscapes with precision. Their value proposition is anchored in a deep bench of technical expertise, boasting over a century of combined experience, which ensures that product commercialization is both compliant and expedited.
How much funding has Founders Science Group raised?
Founders Science Group has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2021): $89K with participation from PPP
Key Investors in Founders Science Group
PPP
Public-Private Partnership
What's next for Founders Science Group?
With the recent infusion of capital, Founders Science Group is poised to accelerate its strategic roadmap, focusing on the expansion of its laboratory infrastructure and the enhancement of its proprietary testing methodologies. As the firm transitions through its current Series B/C stage, the primary objective remains the scaling of its service offerings to meet the rising demand for high-quality, compliant analytical solutions. Future initiatives will likely prioritize the integration of advanced diagnostic technologies and the broadening of its client base, ensuring that the company remains at the forefront of the life sciences and personal care testing market. This strategic pivot is expected to drive long-term value for stakeholders while maintaining the high standards of quality that define the organization.
See full Founders Science Group company page
